RegWardenFDA facility compliance records
Recall

Class II — Roche Diagnostics Operations, Inc.

Recalling firmRoche Diagnostics Operations Inc.
Registered facilityView this company's 14 registered facilities → (openFDA recall records do not name a specific facility)
ClassificationClass II
StatusTerminated
ReasonHomocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules
ProductRoche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.
Quantity82 units (US)
DistributionUS Nationwide distribution in the states of NJ, HI, IA.
Initiated2019-10-04
Classified2019-12-13
Terminated2020-10-09
Recall numberZ-0679-2020
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Roche Diagnostics Operations, Inc. (Z-0679-2020).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/84018/

Not open yet

Alerts for Roche Diagnostics Operations Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.